Delray Beach, FL, Sept. 03, 2026 (GLOBE NEWSWIRE) -- MarketsandMarkets™ projects the global urology devices market will grow from USD 34.56 billion in 2025 to USD 46.26 billion by 2030, at a CAGR of 6.0% during the forecast period. Market growth is driven by the rising prevalence of urological diseases, chronic metabolic conditions, and lifestyle-related disorders. The increasing incidence of benign prostatic hyperplasia, urological malignancies, and kidney disease has further increased the need for advanced urology devices. The emergence of advanced diagnostic testing methodologies, particularly minimally invasive endoscopic techniques, is also driving demand for technologically advanced devices that provide diagnostic precision and procedural accuracy. Growing awareness among healthcare providers and patients regarding advanced treatment options and improved outcomes through urological interventions is further contributing to market expansion, particularly in emerging healthcare markets.

Get PDF Brochure - Market Data & Segmentation: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=173062212

Key Market Highlights

  • Market size, 2025: USD 34.56 billion
  • Market forecast, 2030: USD 46.26 billion
  • Growth rate: CAGR of 6.0% (2025–2030)
  • Largest product segment: Instruments
  • Largest application segment: Kidney diseases
  • Largest end-user segment: Hospitals
  • Largest regional market: North America
  • Key growth opportunity: Emerging economies
  • Key players: Fresenius Medical Care AG & Co. KGaA, Boston Scientific Corporation, Becton, Dickinson and Company, B. Braun Melsungen AG, Cardinal Health, Olympus Corporation, Intuitive Surgical, Coloplast A/S, Stryker Corporation, Teleflex Incorporated, Convatec Group PLC, and Medtronic PLC.

Why This Market Matters

The rising incidence of urological diseases and chronic lifestyle-related conditions is creating sustained demand for urology devices. Diseases such as diabetes and cancer can contribute to urological complications, increasing the need for regular diagnostic testing, disease management, and treatment interventions. The growing global focus on preventive healthcare and early diagnosis is further supporting the adoption of advanced urological technologies across hospitals, dialysis centers, and clinics.

The market is also benefiting from an aging population, increasing healthcare expenditure, and expanding healthcare infrastructure. Rising trauma and accident cases are creating additional demand for emergency urological interventions, while technological advancements in minimally invasive procedures are improving disease detection and treatment outcomes.

Market Overview

The urology devices market encompasses a broad range of products used for the diagnosis, surgery, and treatment of urological diseases, including chronic kidney disease, renal failure, urinary stones, benign prostatic hyperplasia, pelvic organ prolapse, prostate cancer, kidney cancer, bladder cancer, and erectile dysfunction. Products include endoscopes, lithotripters, dialysis equipment, urinary catheters, robotic surgical systems, nephrology devices, and other therapeutic and diagnostic instruments.

Technological advancements in minimally invasive and robotic-assisted procedures are reshaping the market. The increasing use of advanced imaging, endoscopy, and robotic systems is helping improve procedural efficiency and patient outcomes. Investment in new hospitals, surgical centers, and dialysis facilities across developed and emerging markets is also creating additional demand for advanced urology equipment.

Analyst Perspective

Emerging economies represent a significant growth opportunity for urology device manufacturers. Improving healthcare infrastructure, favorable regulations, increasing healthcare expenditure, and expanding patient populations are creating a favorable environment for adoption. Supportive government policies, particularly in Asia Pacific, are fostering innovation and accessibility in the medical device sector.

The rapid expansion of the middle-class population and private healthcare sector is further increasing demand for advanced medical technologies. Rising disposable incomes and greater healthcare awareness are encouraging manufacturers to develop strategies and products that address the evolving healthcare needs of emerging markets.

However, the high degree of consolidation among key players remains a significant restraint. Major companies have strong brand recognition, extensive product portfolios, and substantial R&D capabilities, creating high entry barriers for new participants. High capital requirements, infrastructure needs, and the cost of minimally invasive and robotic systems can also restrict adoption, particularly among smaller healthcare facilities.

Speak to Our Analyst - Get Custom Insights: https://www.marketsandmarkets.com/Enquiry_Before_BuyingNew.asp?id=173062212

Segment Analysis

By product, the urology devices market is segmented into instruments and consumables & accessories. The instruments segment holds the larger market share, driven by extensive use in diagnostic, surgical, and therapeutic urological procedures. Endoscopes, resectoscopes, lithotripters, and cystoscopes are essential for a wide range of minimally invasive and complex procedures. Their higher cost, technological sophistication, and recurring use across healthcare facilities contribute to the segment's dominant market position.

Consumables and accessories, including catheters, guidewires, and drainage bags, play an important role in supporting daily clinical operations. However, instruments remain the dominant contributor to market revenue due to their higher value and broad application across urological procedures.

By application, the market is segmented into kidney diseases, urological cancers, pelvic organ prolapse, benign prostatic hyperplasia, urinary incontinence, erectile dysfunction, urinary stones, and other urological conditions. Kidney disease applications account for the largest share, driven by the increasing prevalence of chronic kidney disease and growing demand for advanced diagnostic and therapeutic solutions.

Urology devices play an important role in kidney disease management through procedures such as dialysis, nephroscopy, and minimally invasive interventions. The growing burden of kidney diseases and expansion of renal care infrastructure continue to support demand for urology devices.

By end user, the market is segmented into hospitals, ambulatory surgical centers, clinics, dialysis centers, and home care settings. Hospitals account for the largest share, supported by high volumes of urological procedures, advanced diagnostic capabilities, and specialized urology departments.

ASCs and clinics are also significant end users due to the increasing adoption of minimally invasive and outpatient urological procedures. Dialysis centers contribute notably because of the rising prevalence of chronic kidney disease, while home care settings are experiencing steady growth due to increasing use of portable and patient-friendly urology devices for long-term care.

Regional Analysis

North America is experiencing steady growth in the urology devices market, supported by well-established healthcare infrastructure, advanced diagnostic capabilities, and high healthcare expenditure. Increasing prevalence of kidney diseases, urinary incontinence, and prostate conditions is fueling demand for diagnostic and therapeutic solutions.

The region also benefits from technological advancements in minimally invasive and robotic-assisted procedures, favorable reimbursement frameworks, and the strong presence of leading medical device manufacturers. Growing adoption of home-based urology care and ongoing product innovation further strengthen North America's position in the global market.

Emerging economies, particularly in Asia Pacific, are presenting strong growth opportunities. Improving healthcare infrastructure, supportive government policies, expanding private healthcare sectors, rising disposable incomes, and increasing healthcare awareness are driving demand for advanced urology devices in these markets.

Key Industry Trends

  • Rising incidence of urological diseases
  • Growing prevalence of chronic kidney disease
  • Increasing incidence of urological cancers
  • Growing geriatric population
  • Increasing adoption of minimally invasive procedures
  • Rising use of robotic-assisted surgery
  • Advancements in endoscopic diagnostic techniques
  • Growing investment in hospitals and surgical centers
  • Expansion of dialysis and renal care infrastructure
  • Increasing adoption of advanced imaging technologies
  • Growing patient awareness of urological treatment options
  • Expansion of home-based urology care
  • Rising demand for portable and patient-friendly devices
  • Increasing healthcare expenditure in emerging markets.

Competitive Landscape

The urology devices market is highly consolidated, with major players benefiting from strong brand presence, significant R&D capabilities, extensive distribution networks, and comprehensive product portfolios. The top five players account for approximately 35% of the total market share.

Key companies compete through product innovation, strategic partnerships, collaborations, acquisitions, mergers, expansions, and product launches and approvals. These strategies are aimed at strengthening geographic presence, expanding product portfolios, and addressing growing demand for minimally invasive and technologically advanced urological procedures.

Related Reports
North America Urology Devices Market
Europe Urology Devices Market

CONTACT: About MarketsandMarkets™:

MarketsandMarkets™ has been recognized as one of America's Best Management Consulting Firms by Forbes, as per their recent report.

MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe.

Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem.

The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.

Built on the 'GIVE Growth' principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore™, which integrates research and provides ecosystem-wide visibility into revenue shifts.

To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter , LinkedIn and Facebook .

Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com
Visit Our Website: https://www.marketsandmarkets.com/